MX369610B - Metodos, dispositivos y sistemas para analisis de muestras. - Google Patents

Metodos, dispositivos y sistemas para analisis de muestras.

Info

Publication number
MX369610B
MX369610B MX2015013596A MX2015013596A MX369610B MX 369610 B MX369610 B MX 369610B MX 2015013596 A MX2015013596 A MX 2015013596A MX 2015013596 A MX2015013596 A MX 2015013596A MX 369610 B MX369610 B MX 369610B
Authority
MX
Mexico
Prior art keywords
assay
subsequent
performance
systems
methods
Prior art date
Application number
MX2015013596A
Other languages
English (en)
Other versions
MX2015013596A (es
Inventor
Elizabeth A Holmes
Daniel Young
Original Assignee
Theranos Ip Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theranos Ip Co Llc filed Critical Theranos Ip Co Llc
Publication of MX2015013596A publication Critical patent/MX2015013596A/es
Publication of MX369610B publication Critical patent/MX369610B/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q3/00—Condition responsive control processes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5094—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for blood cell populations
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • G01N2333/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
    • G01N2333/16—HIV-1, HIV-2
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70546—Integrin superfamily, e.g. VLAs, leuCAM, GPIIb/GPIIIa, LPAM
    • G01N2333/70557—Integrin beta3-subunit-containing molecules, e.g. CD41, CD51, CD61
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70596—Molecules with a "CD"-designation not provided for elsewhere in G01N2333/705
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/10—Detection of antigens from microorganism in sample from host

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Ecology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Theoretical Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Sustainable Development (AREA)
  • Biophysics (AREA)
  • Automatic Analysis And Handling Materials Therefor (AREA)

Abstract

La presente invención se refiere a métodos, dispositivos y sistemas para analizar muestras biológicas. Se puede analizar una biológica para la detectar la presencia de un analito en un ensayo inicial, y la realización de, o método de realización de o un ensayo subsiguiente puede ser dependiente de los resultados del ensayo inicial. Por ejemplo, lo siguiente puede ser dependiente de los resultados de un ensayo anterior: si o no se realiza un ensayo subsiguiente; que ensayo subsiguiente se realiza; el método para realizar un ensayo subsiguiente; el orden de realización de una secuencia de ensayos subsiguientes; los pasos, u orden de pasos, realizados en un ensayo subsiguiente; la sincronización de la realización de un ensayo subsiguiente; la elección de un reactivo usado en un ensayo subsiguiente; el método de detección usado en un ensayo subsiguiente; y otros particulares de ensayos pueden ser dependientes de los resultados de un ensayo anterior.
MX2015013596A 2013-03-27 2014-03-27 Metodos, dispositivos y sistemas para analisis de muestras. MX369610B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361805900P 2013-03-27 2013-03-27
PCT/US2014/032071 WO2014160891A1 (en) 2013-03-27 2014-03-27 Methods, devices, and systems for sample analysis

Publications (2)

Publication Number Publication Date
MX2015013596A MX2015013596A (es) 2016-02-05
MX369610B true MX369610B (es) 2019-11-13

Family

ID=51625530

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015013596A MX369610B (es) 2013-03-27 2014-03-27 Metodos, dispositivos y sistemas para analisis de muestras.

Country Status (13)

Country Link
US (1) US11162946B2 (es)
EP (2) EP2979089B1 (es)
JP (4) JP2016521353A (es)
KR (1) KR20150134383A (es)
CN (1) CN105264374A (es)
AU (1) AU2014241170A1 (es)
BR (1) BR112015024266A2 (es)
CA (1) CA2907504C (es)
ES (1) ES2756098T3 (es)
HK (1) HK1217990A1 (es)
MX (1) MX369610B (es)
SG (1) SG11201507967WA (es)
WO (1) WO2014160891A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160068613A1 (en) 2013-04-29 2016-03-10 Hoffmann-La Roche Inc. Fc-receptor binding modified asymmetric antibodies and methods of use
CA2932364A1 (en) 2014-01-15 2015-07-23 F. Hoffmann-La Roche Ag Fc-region variants with improved protein a-binding
CA2960927A1 (en) * 2014-09-26 2016-03-31 Sofradim Production System and method for early detection of post-surgery infection
CN115634721A (zh) * 2017-02-16 2023-01-24 Essenlix 公司 基于qmax卡的测定装置和方法
CN113474662B (zh) * 2018-12-28 2026-01-06 贝克曼库尔特有限公司 临床分析仪自动化系统诊断
KR102212748B1 (ko) * 2019-07-31 2021-02-04 국방과학연구소 소형 생물입자 식별장치
GB2592082B (en) * 2019-07-31 2023-11-01 Agency Defense Dev Small apparatus for identifying biological particles
MX2022005183A (es) 2019-10-29 2022-08-08 Quantum Si Inc Bombeo peristáltico de fluidos y métodos, sistemas y dispositivos asociados.
BR112022008127A2 (pt) * 2019-10-29 2022-08-23 Quantum Si Inc Sistemas e métodos para preparação de amostras
CN111282848B (zh) * 2020-03-13 2021-11-30 上海纽脉医疗科技有限公司 一种生物组织的筛选方法及生物组织筛选装置
TW202325564A (zh) 2021-12-24 2023-07-01 日商島野股份有限公司 用於人力驅動車之控制裝置、及空氣壓調整裝置
CN117871879A (zh) * 2024-03-12 2024-04-12 深圳市深水龙岗水务集团有限公司 自动化水质检测系统及方法

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5225538A (en) 1989-02-23 1993-07-06 Genentech, Inc. Lymphocyte homing receptor/immunoglobulin fusion proteins
EP0397424A3 (en) 1989-05-08 1991-08-21 Biotrack, Inc. Multiple analysis system
CA2084987C (en) 1990-06-11 2007-02-13 Gilead Sciences, Inc. Nucleic acid ligands
EP0473065A3 (en) * 1990-08-29 1992-08-26 Abbott Laboratories Simultaneous assay for detecting two or more analytes
US6720166B2 (en) 1994-02-14 2004-04-13 Abbott Laboratories Non-a, non-b, non-c, non-c, non-d, non-e hepatitis reagents and methods for their use
US5795784A (en) * 1996-09-19 1998-08-18 Abbott Laboratories Method of performing a process for determining an item of interest in a sample
US5731156A (en) * 1996-10-21 1998-03-24 Applied Imaging, Inc. Use of anti-embryonic hemoglobin antibodies to identify fetal cells
US6929953B1 (en) * 1998-03-07 2005-08-16 Robert A. Levine Apparatus for analyzing biologic fluids
US20030095897A1 (en) * 2001-08-31 2003-05-22 Grate Jay W. Flow-controlled magnetic particle manipulation
US7700074B2 (en) 2002-02-07 2010-04-20 Pettegrew Jay W Method and system for diagnosis of neuropsychiatric disorders including chronic alcoholism
US7211396B2 (en) * 2002-04-18 2007-05-01 Antibodyshop A/S Antibody pairs and kits for immunochemical determination of mannan-binding lectin
WO2004005472A2 (en) * 2002-07-02 2004-01-15 Southern Research Institute Inhibitors of ftsz and uses thereof
JP4299597B2 (ja) * 2002-07-29 2009-07-22 シスメックス株式会社 血液分析装置及び方法
US7122153B2 (en) * 2003-01-08 2006-10-17 Ho Winston Z Self-contained microfluidic biochip and apparatus
CN102072961A (zh) * 2003-07-17 2011-05-25 三菱化学美迪恩斯株式会社 用于自动测定的检测盒和使用该检测盒的测定装置
US7550112B2 (en) * 2003-11-14 2009-06-23 Oakville Hong Kong Company Limited Sample collection cup with integrated activatable sample analysis system
US20050106642A1 (en) * 2003-11-19 2005-05-19 Lipps Binie V. Saliva test for early diagnosis of cancers
US20050227370A1 (en) * 2004-03-08 2005-10-13 Ramel Urs A Body fluid analyte meter & cartridge system for performing combined general chemical and specific binding assays
US20060004526A1 (en) 2004-07-01 2006-01-05 Ambion, Inc. System and method for processing results of a complex genetic test
US20060292647A1 (en) * 2004-12-03 2006-12-28 Green Lawrence R Reflex supplemental testing - A rapid, efficient and highly accurate method to identify subjects with an infection, disease or other condition
EP1844426A4 (en) * 2005-02-01 2016-09-07 Amnis Corp Blood analysis using a flow imaging cytometer
US20080124738A1 (en) * 2005-03-01 2008-05-29 Pritest, Inc Compositions and methods of testing for tuberculosis and mycobacterium infection
AU2006235057A1 (en) * 2005-04-07 2006-10-19 Rapid Medical Diagnostics, Inc. Device and methods for detecting an analyte in a sample
DE112006000937T5 (de) 2005-04-15 2008-08-28 Thermo Crs Ltd., Burlington Verfahren und System zur Prüfung von Proben
US20070111225A1 (en) * 2005-08-10 2007-05-17 California Institute Of Technology System and method for monitoring an analyte
AU2007211085A1 (en) * 2006-01-27 2007-08-09 Tripath Imaging, Inc. Methods for identifying patients with an increased likelihood of having ovarian cancer and compositions therefor
JP4922682B2 (ja) 2006-06-29 2012-04-25 シスメックス株式会社 分析装置
US8097419B2 (en) * 2006-09-12 2012-01-17 Longhorn Vaccines & Diagnostics Llc Compositions and method for rapid, real-time detection of influenza A virus (H1N1) swine 2009
US8290625B2 (en) * 2007-04-04 2012-10-16 Beckman Coulter, Inc. Flow cytometer sorter
US20090155788A1 (en) * 2007-05-22 2009-06-18 Abbas Alexander R Gene expression markers for inflammatory bowel disease
US8112229B2 (en) * 2007-05-31 2012-02-07 Abbott Laboratories Method for determining the order of execution of assays of a sample in a laboratory automation system
CA2734136A1 (en) * 2007-08-21 2009-02-26 Peter E. Rising Microbial screen test
US20100267041A1 (en) * 2007-09-14 2010-10-21 Predictive Biosciences, Inc. Serial analysis of biomarkers for disease diagnosis
CA3170924A1 (en) 2007-10-02 2009-04-09 Labrador Diagnostics Llc Modular point-of-care devices and uses thereof
US20110245087A1 (en) * 2008-03-18 2011-10-06 Gunter Weiss Method for optimizing and validating an assay for determining the presence or absence of a medical condition
US8008033B2 (en) * 2008-10-15 2011-08-30 Gilles Reza Georges Monif Fuidi herd management schema
JP4997613B2 (ja) * 2009-12-15 2012-08-08 独立行政法人産業技術総合研究所 ヒト神経幹細胞に選択的なモノクローナル抗体及びこれを用いたスクリーニング方法
US12158478B2 (en) * 2010-04-19 2024-12-03 Meso Scale Technologies, Llc. Systems of monitoring systems and methods thereof
US8409807B2 (en) * 2010-10-22 2013-04-02 T2 Biosystems, Inc. NMR systems and methods for the rapid detection of analytes
US20150064695A1 (en) * 2010-12-17 2015-03-05 Celula Inc. Methods for screening and diagnosing genetic conditions
US20140170735A1 (en) * 2011-09-25 2014-06-19 Elizabeth A. Holmes Systems and methods for multi-analysis
US8380541B1 (en) 2011-09-25 2013-02-19 Theranos, Inc. Systems and methods for collecting and transmitting assay results
US9250229B2 (en) * 2011-09-25 2016-02-02 Theranos, Inc. Systems and methods for multi-analysis
US20140287423A1 (en) * 2011-10-28 2014-09-25 Life Technologies Corporaton Device and method for apportionment and manipulation of sample volumes
CN102768271B (zh) * 2012-08-10 2014-06-04 爱威科技股份有限公司 样本分析方法及综合样本分析仪
CA2898477A1 (en) 2013-02-18 2014-08-21 Theranos, Inc. Systems and methods for multi-analysis

Also Published As

Publication number Publication date
EP3633369A1 (en) 2020-04-08
KR20150134383A (ko) 2015-12-01
JP2021035372A (ja) 2021-03-04
BR112015024266A2 (pt) 2017-07-18
CA2907504A1 (en) 2014-10-02
US11162946B2 (en) 2021-11-02
CN105264374A (zh) 2016-01-20
ES2756098T3 (es) 2020-04-27
EP2979089A1 (en) 2016-02-03
JP2019090814A (ja) 2019-06-13
JP2022153471A (ja) 2022-10-12
SG11201507967WA (en) 2015-10-29
HK1217990A1 (zh) 2017-01-27
MX2015013596A (es) 2016-02-05
EP2979089B1 (en) 2019-08-14
JP2016521353A (ja) 2016-07-21
US20160231320A1 (en) 2016-08-11
EP2979089A4 (en) 2016-03-02
AU2014241170A1 (en) 2015-09-24
CA2907504C (en) 2023-01-17
WO2014160891A1 (en) 2014-10-02

Similar Documents

Publication Publication Date Title
MX369610B (es) Metodos, dispositivos y sistemas para analisis de muestras.
MY198081A (en) Urinalysis device and dry reagent for quantitative urinalysis
BR112018000851A2 (pt) sistemas e métodos para detecção e quantificação aprimoradas de analitos
WO2015128272A3 (en) Photo-selective method for biological sample analysis field
EP4435407A3 (en) Blood analysis method, control device, and blood cell analyzer
NZ728582A (en) Instrument for analyzing biological samples and reagents
MX380165B (es) Dispositivo integrado de fuente-pixel activo para el analisis rapido de especimenes biologicos y quimicos.
MX2015014479A (es) Dispositivo de transferencia de muestras de fluidos biologicos y sistema de separacion y analisis de fluidos biologicos.
BR112017021256A2 (pt) dispositivos e métodos para a análise de amostras
MX2016002632A (es) Dispositivo y metodos para usar un dispositivo para la deteccion de hiperamoniemia.
MX2015014485A (es) Dispositivo de transferencia de muestreo de fluidos biologicos y sistema de separacion y analisis de fluidos biologicos.
MX373696B (es) Dispositivos, metodos y equipos de prueba para el analisis electronico de analitos.
WO2015070037A3 (en) Polynucleotide conjugates and methods for analyte detection
EP4411387A3 (en) Integrated sample processing system with multiple detection capability
MY170164A (en) Aptamer-based multiplexed assays
MX2020003523A (es) Deteccion de dimetilarginina simetrica.
EP4513499A3 (en) Method and device for analyzing target analyte in sample
WO2016198833A3 (en) Methods for analysing a urine sample
MX2019001134A (es) Sistemas y metodos para la deteccion de reacciones quimioluminiscentes.
HK1219534A1 (zh) 分析仪器系统
WO2016209773A9 (en) Improved assays and methods for allergen detection
BR112019007081A2 (pt) sistema de análise e método para testagem de uma amostra
MX2019000592A (es) Dispositivo dispensador de reactivos analiticos liquidos, y kits analiticos y metodos de uso relacionados.
EP3736571A4 (en) METHOD, REAGENT AND CHIP FOR MEASURING THE ANALYTE CONCENTRATION IN A BIOLOGICAL SAMPLE
EA201500377A1 (ru) Способ обнаружения анализируемого вещества и определение его концентрации с использованием намагничиваемых гранул

Legal Events

Date Code Title Description
GB Transfer or rights

Owner name: THERANOS IP COMPANY, LLC

FG Grant or registration